Table 1 Relationship between GMDS expression and clinical pathological parameters (cases,%)by IHC staining
From: GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma
Clinical pathological parameters | Case number | HSDL2 expression status | P value | |
|---|---|---|---|---|
low | high | |||
Ages(year) | ||||
≤ 65 | 111 | 53 | 58 | 0.080 |
> 65 | 54 | 18 | 36 | |
Gender | ||||
Male | 88 | 39 | 49 | 0.776 |
Female | 76 | 32 | 44 | |
Tumor diameter(cm) | ||||
≤ 5 | 137 | 62 | 75 | 0.203 |
> 5 | 28 | 9 | 19 | |
Grades | ||||
I/II | 126 | 54 | 72 | 0.936 |
III | 39 | 17 | 22 | |
T staging | ||||
T1/T2 | 128 | 55 | 73 | 0.653 |
T3/T4 | 37 | 16 | 21 | |
N migration | ||||
Nx/N0 | 99 | 42 | 57 | 0.653 |
N1/N2/N3 | 63 | 29 | 34 | |
M metastasis | ||||
M0 | 159 | 70 | 89 | 0.287 |
M1 | 5 | 1 | 4 | |
TNM staging | ||||
TNM1/2 | 112 | 51 | 61 | 0.580 |
TNM3/4 | 49 | 20 | 29 | |